EPITHELIAL OVARIAN CANCER

Clinical trials for EPITHELIAL OVARIAN CANCER explained in plain language.

Never miss a new study

Get alerted when new EPITHELIAL OVARIAN CANCER trials appear

Sign up with your email to follow new studies for EPITHELIAL OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 23 Not yet recruiting 1 Not yet finished but already full! 4 Completed 9 Terminated 3

New hope for hard-to-treat ovarian cancer: experimental drug BL-M07D1 enters final testing phase

Disease control Not yet recruiting

This study tests a new drug called BL-M07D1 against standard chemotherapy in about 404 people with HER2-positive ovarian, fallopian tube, or peritoneal cancer that no longer responds to platinum-based treatments. The goal is to see if BL-M07D1 can slow cancer growth or improve su…

Matched conditions: EPITHELIAL OVARIAN CANCER

Phase: PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated May 15, 2026 11:56 UTC

EPITHELIAL OVARIAN CANCER

Get alerted when new EPITHELIAL OVARIAN CANCER trials appear

New hope for hard-to-treat ovarian cancer: experimental drug BL-M07D1 enters final testing phase